<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: Several single nucleotide polymorphisms (SNPs) in <z:mp ids='MP_0002055'>diabetes</z:mp> risk genes reduce <z:chebi fb="105" ids="17234">glucose</z:chebi>- and/or incretin-induced insulin secretion </plain></SENT>
<SENT sid="1" pm="."><plain>Here, we investigated interactions between glycemia and such <z:mp ids='MP_0002055'>diabetes</z:mp> risk polymorphisms </plain></SENT>
<SENT sid="2" pm="."><plain>RESEARCH DESIGN AND METHODS: Insulin secretion was assessed by insulinogenic index and areas under the curve of C-<z:chebi fb="7" ids="16670">peptide</z:chebi>/<z:chebi fb="105" ids="17234">glucose</z:chebi> in 1,576 subjects using an oral <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance test (OGTT) </plain></SENT>
<SENT sid="3" pm="."><plain>Participants were genotyped for 10 <z:mp ids='MP_0002055'>diabetes</z:mp> risk SNPs associated with β-cell dysfunction: rs5215 (KCNJ11), rs13266634 (SLC30A8), rs7754840 (CDKAL1), rs10811661 (CDKN2A/2B), rs10830963 (MTNR1B), rs7903146 (TCF7L2), rs10010131 (WFS1), rs7923837 (HHEX), rs151290 (KCNQ1), and rs4402960 (IGF2BP2) </plain></SENT>
<SENT sid="4" pm="."><plain>Furthermore, the impact of the interaction between genetic variation in TCF7L2 and glycemia on changes in insulin secretion was tested in 315 individuals taking part in a lifestyle intervention study </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: For the SNPs in TCF7L2 and WFS1, we found a significant interaction between <z:chebi fb="105" ids="17234">glucose</z:chebi> control and insulin secretion (<z:hpo ids='HP_0000001'>all</z:hpo> P ≤ 0.0018 for <z:chebi fb="105" ids="17234">glucose</z:chebi> × genotype) </plain></SENT>
<SENT sid="6" pm="."><plain>When plotting insulin secretion against <z:chebi fb="105" ids="17234">glucose</z:chebi> at 120 min OGTT, the compromising SNP effects on insulin secretion are most apparent under high <z:chebi fb="105" ids="17234">glucose</z:chebi> </plain></SENT>
<SENT sid="7" pm="."><plain>In the longitudinal study, rs7903146 in TCF7L2 showed a significant interaction with baseline <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance upon change in insulin secretion (P = 0.0027) </plain></SENT>
<SENT sid="8" pm="."><plain><z:mp ids='MP_0005559'>Increased glucose levels</z:mp> at baseline predicted an increase in insulin secretion upon improvement of glycemia by lifestyle intervention only in carriers of the risk alleles </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: For the <z:mp ids='MP_0002055'>diabetes</z:mp> risk genes TCF7L2 and WFS1, which are associated with impaired incretin signaling, the level of glycemia determines SNP effects on insulin secretion </plain></SENT>
<SENT sid="10" pm="."><plain>This indicates the increasing relevance of these SNPs during the progression of <z:e sem="disease" ids="C0362046" disease_type="Disease or Syndrome" abbrv="">prediabetes</z:e> stages toward clinically overt type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>